Emeritus Professor Lloyd Sansom, Former Chair, Pharmaceutical Benefits Advisory Committee, UniSA
Dr Michael Sorich, Associate Professor of Pharmacology, Flinders University
Tuesday 24 September 2013, 6pm for a 6.15pm start
Is the Pharmaceutical Benefits Scheme (PBS) good for cancer patients?
Why are some cancer patients eligible for clinical trials and others are not?
Can the PBS support personalised medicines?
Cancer therapies are amongst some of the most expensive in the world with prices set by a global market that is hard to navigate. The PBS has supported Australians for over 60 years, but with the growth of personalised medicine development there are challenges ahead.
Leaders in their field, Emeritus Professor Lloyd Sansom and Dr Michael Sorich will lead this discussion with an overview of the PBS in Australia, how and why it works as well as the challenges that cancer therapies pose to the current system.
Venue: Function Centre, Flinders Centre for Innovation in Cancer, Flinders Medical Centre campus - click here for a map of the venue or view the map at the bottom of the page.
RSVP: via email or call 8204 5594.